Novel Genetic Insight for Psoriasis: Integrative Genome-wide Analyses in 863 080 Individuals and Proteome-wide Mendelian Randomization

Overview

Journal Brief Bioinform

Publisher Oxford University Press

Date 2025 Jan 30

PMID 39883516

Authors

Shunying Liu

Lingfei Li

Yi Liang

Yang Tan

Xiaoyu Wang

Yanhai Feng

Nian Chen

Xia Lei

Affiliations

Soon will be listed here.

Abstract

Psoriasis affects a significant proportion of the worldwide population and causes an extremely heavy psychological and physical burden. The existing therapeutic schemes have many deficiencies such as limited efficacies and various side effects. Therefore, novel ways of treating psoriasis are urgently needed. A large-scale meta-analysis of psoriasis genome-wide association studies (GWAS) totaling 20 105 cases and 842 975 controls was conducted. Based on the GWAS results, Mendelian randomization (MR) analyses were then performed on three cis-protein quantitative trait loci (pQTL) data in blood. Furthermore, druggability verification and mouse knock-out models were utilized to explore the clinical value of screened proteins. We identified 42 genome-wide significant psoriasis risk variants (P < 5 × 10-8), of which 33 were previously unreported. MR analyses unveiled 19 unique circulating proteins that were associated with psoriasis, among which only AIF1, FCGR3A, NEU1, HSPA1A, TNXB, and ABO were the potential proteins that interacted with psoriasis risk after being analyzed with high evidence of colocalization (PP.H4 > 0.9). In addition, AIF1, FCGR3A, and HSPA1A have been finally determined to be feasible therapeutic targets for psoriasis after being confirmed by druggability verification and specific mouse knock-out models. This large-scale GWAS meta-analysis identified 33 new variants for psoriasis. This study announced that AIF1, FCGR3, and HSPA1A were the unexplored but material variants of psoriasis, thus providing novel and valuable targets for psoriasis treatment and broadening new orientation of drug development for psoriasis.

References

Autieri M, Carbone C . Overexpression of allograft inflammatory factor-1 promotes proliferation of vascular smooth muscle cells by cell cycle deregulation. Arterioscler Thromb Vasc Biol. 2001; 21(9):1421-6. DOI: 10.1161/hq0901.095566. View

Shaw D . Searching the Mouse Genome Informatics (MGI) Resources for Information on Mouse Biology from Genotype to Phenotype. Curr Protoc Bioinformatics. 2016; 56:1.7.1-1.7.16. PMC: 5147750. DOI: 10.1002/cpbi.18. View

Reid C, Griffiths C . Psoriasis and Treatment: Past, Present and Future Aspects. Acta Derm Venereol. 2020; 100(3):adv00032. PMC: 9128930. DOI: 10.2340/00015555-3386. View

Stuart P, Nair R, Ellinghaus E, Ding J, Tejasvi T, Gudjonsson J . Genome-wide association analysis identifies three psoriasis susceptibility loci. Nat Genet. 2010; 42(11):1000-4. PMC: 2965799. DOI: 10.1038/ng.693. View

Bojko A, Ostasz R, Bialecka M, Klimowicz A, Malinowski D, Budawski R . IL12B, IL23A, IL23R and HLA-C*06 genetic variants in psoriasis susceptibility and response to treatment. Hum Immunol. 2018; 79(4):213-217. DOI: 10.1016/j.humimm.2018.02.003. View

Strange A, Capon F, Spencer C, Knight J, Weale M, Allen M . A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1. Nat Genet. 2010; 42(11):985-90. PMC: 3749730. DOI: 10.1038/ng.694. View

Willer C, Li Y, Abecasis G . METAL: fast and efficient meta-analysis of genomewide association scans. Bioinformatics. 2010; 26(17):2190-1. PMC: 2922887. DOI: 10.1093/bioinformatics/btq340. View

Vogelpoel L, Baeten D, de Jong E, Dunnen J . Control of cytokine production by human fc gamma receptors: implications for pathogen defense and autoimmunity. Front Immunol. 2015; 6:79. PMC: 4338787. DOI: 10.3389/fimmu.2015.00079. View

Tichenor M, Sridhar D . Metric partnerships: global burden of disease estimates within the World Bank, the World Health Organisation and the Institute for Health Metrics and Evaluation. Wellcome Open Res. 2019; 4:35. PMC: 6406176. DOI: 10.12688/wellcomeopenres.15011.2. View

10.

Ochoa D, Hercules A, Carmona M, Suveges D, Baker J, Malangone C . The next-generation Open Targets Platform: reimagined, redesigned, rebuilt. Nucleic Acids Res. 2022; 51(D1):D1353-D1359. PMC: 9825572. DOI: 10.1093/nar/gkac1046. View

11.

Chong M, Sjaarda J, Pigeyre M, Mohammadi-Shemirani P, Lali R, Shoamanesh A . Novel Drug Targets for Ischemic Stroke Identified Through Mendelian Randomization Analysis of the Blood Proteome. Circulation. 2019; 140(10):819-830. DOI: 10.1161/CIRCULATIONAHA.119.040180. View

12.

Zhang J, Dutta D, Kottgen A, Tin A, Schlosser P, Grams M . Plasma proteome analyses in individuals of European and African ancestry identify cis-pQTLs and models for proteome-wide association studies. Nat Genet. 2022; 54(5):593-602. PMC: 9236177. DOI: 10.1038/s41588-022-01051-w. View

13.

Kromann B, Olsson A, Zhang Y, Lovendorf M, Skov L, Dyring-Andersen B . Proteins in the Skin and Blood in Patients with Psoriasis: A Systematic Review of Proteomic Studies. Dermatology. 2023; 240(2):317-328. DOI: 10.1159/000533981. View

14.

Winkler T, Day F, Croteau-Chonka D, Wood A, Locke A, Magi R . Quality control and conduct of genome-wide association meta-analyses. Nat Protoc. 2014; 9(5):1192-212. PMC: 4083217. DOI: 10.1038/nprot.2014.071. View

15.

Parisi R, Iskandar I, Kontopantelis E, Augustin M, Griffiths C, Ashcroft D . National, regional, and worldwide epidemiology of psoriasis: systematic analysis and modelling study. BMJ. 2020; 369:m1590. PMC: 7254147. DOI: 10.1136/bmj.m1590. View

16.

Thompson J, Attia J, Minelli C . The meta-analysis of genome-wide association studies. Brief Bioinform. 2011; 12(3):259-69. DOI: 10.1093/bib/bbr020. View

17.

Sieve I, Ricke-Hoch M, Kasten M, Battmer K, Stapel B, Falk C . A positive feedback loop between IL-1β, LPS and NEU1 may promote atherosclerosis by enhancing a pro-inflammatory state in monocytes and macrophages. Vascul Pharmacol. 2018; 103-105:16-28. DOI: 10.1016/j.vph.2018.01.005. View

18.

Lin J, Zhou J, Xu Y . Potential drug targets for multiple sclerosis identified through Mendelian randomization analysis. Brain. 2023; 146(8):3364-3372. PMC: 10393411. DOI: 10.1093/brain/awad070. View

19.

Baliwag J, Barnes D, Johnston A . Cytokines in psoriasis. Cytokine. 2015; 73(2):342-50. PMC: 4437803. DOI: 10.1016/j.cyto.2014.12.014. View

20.

Sun B, Maranville J, Peters J, Stacey D, Staley J, Blackshaw J . Genomic atlas of the human plasma proteome. Nature. 2018; 558(7708):73-79. PMC: 6697541. DOI: 10.1038/s41586-018-0175-2. View